This is not a good year for Johnson & Johnson.
Johnson & Johnson lost a $257.7 million jury verdict in Louisiana for making misleading claims about the safety of the company’s Risperdal antipsychotic drug.
* * * *
The jury found 35,542 violations of the state’s Medical Assistance Programs Integrity Law and imposed a penalty